HiberCell

Genuity Science is a company that specializes in clinco-omics data analysis solutions for researchers in the fields of central nervous system, cardiometabolic, and inflammatory diseases. The company provides a comprehensive global genomics platform that facilitates the study of biological data insights, offering services that include study design, genomic sequencing, data storage, interpretation, secondary analysis, and scalable analytics. By leveraging the human genome, Genuity Science aims to empower organizations to enhance patient health through advanced genomic insights and analysis.

Biothera Pharmaceuticals, Inc., founded in 1997 and based in Eagan, Minnesota, is a biotechnology company that specializes in developing cancer immunotherapy. The firm focuses on a novel drug, Imprime PGG, which acts as a pathogen-associated molecular patterning molecule, effectively functioning as an immunological ignition switch. This mechanism coordinates both innate and adaptive immune responses, enhancing the body's ability to combat cancer. Biothera's product has demonstrated efficacy in combination with monoclonal antibodies in clinical studies for various cancers, including non-small cell lung cancer, colorectal cancer, and chronic lymphocytic leukemia. The company's innovative approach aims to improve the therapeutic outcomes for cancer patients by activating and directing the immune system's natural defenses.